You are here

PFIZER ONCOLOGY PRESS KIT PAGE

evergreen_headers_3_940px.jpg

PLEASE NOTE: All assets on this page are intended for use by media professionals.

Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for patients across a wide range of cancers. For the latest information on our growing pipeline, product portfolio and collaborations with the broader cancer community, visit this page periodically for leadership perspective, fact sheets, videos and other media resources.

We also encourage you to visit our other online resources for additional information on Pfizer Oncology.

Click here to learn more about how Pfizer Oncology is helping to redefine life with cancer.

Click here to learn more about Pfizer’s unique combination approach and pipeline.

PFIZER AT ESMO 2017

At the European Society for Medical Oncology (ESMO) Congress being held from September 8-12, 2017 in Madrid, Pfizer will share new data on 13 of our marketed therapies and investigational compounds across multiple solid tumors and hematologic cancers. Learn more about Pfizer at ESMO:

Pfizer Showcases Latest Progress Against Cancer at ESMO 2017

Pfizer Presents Positive Pivotal Data for PF-05280014, an Investigational Biosimilar to Herceptin® (trastuzumab),* at the European Society for Medical Oncology (ESMO) 2017 Congress

Pfizer Presents Overall Survival Data Of XALKORI In Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer

*Herceptin® is a registered trademark of Genentech, Inc.

Hear from Pfizer Leadership

2017_ASCO_Albert_Bourla.pngRALLYING A GLOBAL MOVEMENT TO FIGHT CANCER » Albert Bourla

Group President, Pfizer Innovative Health

2017_ASCO_Liz_Barrett.pngCOMING TOGETHER TO CONQUER CANCER: HOW TO TURN PROMISE INTO REALITY » Liz Barrett

Global President and General Manager, Pfizer Oncology

2017_ASCO_Matthew_Shaulis.pngTO REDUCE FINANCIAL BURDEN FOR PATIENTS, WE NEED COOPERATION AND COORDINATION » Matthew Shaulis

President, North America Oncology at Pfizer

2017_ASCO_Mace_Rothenberg.pngPIECING IT TOGETHER: SOLVING THE PUZZLE OF CANCER » Mace Rothenberg, MD

Chief Development Officer, Oncology, Pfizer Global Product Development

Videos

TRANSFORMING THE FUTURE OF BREAST CANCER THROUGH SCIENTIFIC INNOVATION

Hear from Maria Koehler, MD, PhD and Matthew Ellis, MD about recent progress.

PFIZER TALKS POSSIBILITIES

Taking the temperature of immuno-oncology.

Pfizer Oncology B-Roll

Includes footage of Pfizer headquarters, research facilities and a physician/patient exam for use by media outlets.

Pfizer Immuno-oncology Video

Recent immunotherapy advances represent new hope for patients with cancer. At Pfizer, we’re primed to go further – and take the next big leap in immuno-oncology.